David G. Miller, RPh, on the Drug Quality and Security Act

Published Online: Tuesday, November 12, 2013
Follow Pharmacy_Times:
In this video, David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists (IACP), discusses H.R. 3204, the Drug Quality and Security Act, which passed the House of Representatives on September 25, 2013. Miller explains that IACP opposes the bill because it reaffirms section 503A of the Federal Food, Drug, and Cosmetic Act rather than fixing its problems. This video was recorded at the National Community Pharmacists Association 115th Annual Convention in Orlando.

Related Articles
A New Jersey-based compounding pharmacy has voluntarily recalled 4 prescription preparations distributed in 4 states due to potential contamination.
A bill introduced in the House of Representatives would exclude medical marijuana products from the Controlled Substances Act’s definition of marijuana.
New legislation comes 2 years after contaminated steroids from a Massachusetts compounding pharmacy cause meningitis outbreak.
Latest Issues
$auto_registration$